Table 1.
Main papers showing lipid rafts of cellular and nuclear membranes as targets of anticancer molecules.
| MOLECULES TARGETING LIPID RAFTS IN CANCER | |
|---|---|
| Cell Membrane Lipid Rats | |
| Hydroxypropyl-β-cyclodextrin | [100] |
| Nystatin | [101] |
| TGF-β1 | [100,101] |
| Podoplanin | [102] |
| Caveolin-1 | [103] |
| Flotillin | [104,105] |
| CD44 | [106,107,108] |
| SK3 | [109] |
| Orai1 | [109] |
| TRAIL | [111,117] |
| Edelfosine | [112] |
| Endocannabinoids | [113] |
| Liver X receptor | [118] |
| γ-tocotrienol | [119] |
| Bufalin | [120] |
| Resveratrol | [121] |
| Methyl beta cyclodextrin | [122] |
| Epidermal growth factor receptor | [123] |
| β-elemene | [124] |
| Fumonisin B1 | [125] |
| Antagonist 20S-protopanaxadiol | [126] |
| Lovastatin | [127] |
| CXCL12 | [128] |
| Temozolomide | [129] |
| Nuclear membrane lipid rafts | |
| Gentamicin | [130] |
| Daunorubicin | [131] |